Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis.

PropertyValue
has minor subject area list Adolescent; Adult; Aged; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome
information resource reference Menter A, Kosinski M, Bresnahan BW, Papp KA, Ware JE. Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis. J Drugs Dermatol. 2004 Jan-Feb; 3(1):27-38.
label Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis.

Search Criteria
  • randomized
  • clinical
  • trials